Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-a gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity

[1]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[2]  L. Groop,et al.  Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[3]  J. Olefsky,et al.  Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. , 1995, The American journal of clinical nutrition.

[4]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[5]  C. Bogardus,et al.  Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. , 1990, The American journal of physiology.

[6]  D. Accili,et al.  Mutations in the insulin receptor gene. , 1992, Endocrine reviews.

[7]  B. Spiegelman,et al.  Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.

[8]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[9]  B. Goldstein,et al.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. , 1995, The Journal of clinical investigation.

[10]  R. Considine,et al.  Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. , 1995, The Journal of clinical investigation.

[11]  J. Olefsky,et al.  Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. , 1994, The Journal of clinical endocrinology and metabolism.

[12]  R. Roth,et al.  A nonradioactive assay for the insulin receptor tyrosine kinase: use in monitoring receptor kinase activity after activation of overexpressed protein kinase C alpha and high glucose treatment. , 1995, Analytical biochemistry.

[13]  P. Casellas,et al.  Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. , 1992, The Journal of biological chemistry.

[14]  G. Dohm,et al.  Skeletal Muscle Content of Membrane Glycoprotein PC-1 in Obesity: Relationship to Muscle Glucose Transport , 1996, Diabetes.

[15]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[16]  R. Roth,et al.  Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells. , 1990, The Journal of biological chemistry.

[17]  J. Larrick,et al.  Competitive PCR , 1992, Nature.

[18]  T. Yano,et al.  Elevated nucleotide pyrophosphatase activity in cultured skin fibroblasts from patients with Lowe's syndrome. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[19]  A. Grupe,et al.  Inhibition of Insulin Receptor Phosphorylation by PC-1 Is Not Mediated by the Hydrolysis of Adenosine Triphosphate or the Generation of Adenosine (*) , 1995, The Journal of Biological Chemistry.

[20]  J. Goding,et al.  Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissues. , 1988, Journal of immunology.

[21]  L. Liotta,et al.  cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. , 1994, The Journal of biological chemistry.

[22]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[23]  R. Bergman,et al.  Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin , 1995, Diabetes.

[24]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[25]  G. Reaven,et al.  Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus , 1995, Nature.

[26]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[27]  M. White,et al.  A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. , 1989, The Journal of biological chemistry.

[28]  D. Accili,et al.  Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM? , 1994, Diabetes.

[29]  H. Klein,et al.  Elevation of Serum Insulin Concentration During Euglycemic Hyperinsulinemic Clamp Studies Leads to Similar Activation of Insulin Receptor Kinase in Skeletal Muscle of Subjects With and Without NIDDM , 1995, Diabetes.

[30]  W. Pories,et al.  Insulin-Receptor Kinase Activity of Adipose Tissue From Morbidly Obese Humans With and Without NIDDM , 1987, Diabetes.

[31]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[32]  N. Rebbe,et al.  Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. , 1993, Molecular immunology.

[33]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[34]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[35]  M. V. Doyle,et al.  Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Zancanaro,et al.  Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. , 1989, The Journal of clinical endocrinology and metabolism.

[37]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[38]  H. Maegawa,et al.  Impaired Autophosphorylation of Insulin Receptors From Abdominal Skeletal Muscles in Nonobese Subjects With NIDDM , 1991, Diabetes.

[39]  C. Bogardus.  Insulin Resistance in the Pathogenesis of NIDDM in Pima Indians , 1993, Diabetes Care.

[40]  R. Vigneri,et al.  A reduced glut 4 content in adipose tissue is not an early defect in the development of human insulin resistance , 1995 .

[41]  J. Flier,et al.  Normal Insulin-Receptor cDNA Sequence in Pima Indians With NIDDM , 1989, Diabetes.

[42]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[43]  H. Klein,et al.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. , 1987, The Journal of clinical investigation.

[44]  P. Björntorp,et al.  Glucose uptake in human adipose tissue. , 1987, Metabolism: clinical and experimental.

[45]  C. Kahn,et al.  Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. , 1988, The Journal of clinical endocrinology and metabolism.

[46]  J. Goding,et al.  Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. , 1994, European journal of biochemistry.